Helping protect and enhance your company’s value
Mitigating the growing numbers of risks of post-approval activities has many hurdles and is a critical task for life sciences companies. Furthermore, organizations require results-proven professionals to develop a strategy that aligns medical affairs activities with core business goals and that is supported by real-world evidence (RWE).
At Baker Tilly, our experienced life sciences industry specialists have foresight into the future state of medical affairs and provide the strategic lens that medical device and pharmaceutical companies need to achieve success now, and for tomorrow. Our specialized professionals understand the intricacies of navigating the complex demands of physicians, hospitals and hospital systems, and health plans to help organizations disseminate accurate and effective information on product value. These solutions take into account compliance and accreditation standards, key opinion leader (KOL) management, medical information and education, and evidence generation in developing comprehensive medical affairs strategies.